Journal of Contemporary Brachytherapy
eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
3/2025
vol. 17
 
Share:
Send email
Share:
abstract:
Case report

Orchiepididymitis as a rare complication of TURP performed four weeks after high-dose-rate brachytherapy for prostate cancer

Justyna Rembak-Szynkiewicz
1
,
Patrycja Mazgaj
1
,
Tomasz Szopiński
2, 3
,
Arkadiusz Badziński
4, 5
,
Anna Hebda
1
,
Piotr Wojcieszek
6

  1. Radiology and Diagnostic Imaging Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
  2. Department of Urology, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
  3. Department of Urology, Mazovia Hospital, Warsaw, Poland
  4. Silesian Nanomicroscopy Center, Silesia LabMed: Research and Implementation Center, Zabrze, Medical University of Silesia in Katowice, Poland
  5. Institute of Linguistics, University of Silesia, Katowice, Poland
  6. Brachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
J Contemp Brachytherapy 2025; 17, 3: 202–212
DOI: https://doi.org/10.5114/jcb.2025.152544
Online publish date: 2025/06/30
View full text Get citation
 
The aim of this paper was to present a rare complication of orchiepididymitis in a patient treated with brachytherapy (BT) for prostate cancer, who underwent trans-ureteral resection of the prostate (TURP) four weeks after BT.

A 73-year-old patient with prostate cancer (intermediate-risk group) was eligible for high-dose-rate (HDR) BT combined with androgen deprivation therapy (ADT) for 6 months (leuprorelin). Due to increased symptoms, such as urinary retention after BT, the patient required catheterization. Additionally, bacterial inflammation in the lower urinary tract and prostate was present. Due to prolonged micturition disorders, TURP was performed, leading to chronic orchiepididymitis four months after completion of BT and three months after catheter removal following TURP.

Due to long-term inflammation, which was resistant to treatment, the left testicle with left epididymis was removed. Unfortunately, inflammatory symptoms occurred post-operatively in the bed and the left groin. Since these symptoms of varying severity continued, anti-inflammatory drugs and analgesics were introduced.

TURP performed too quickly after HDR-BT might cause severe complications. Extreme caution regarding TURP should be exercised in patients undergoing BT. Conservative and pharmacological treatment must be introduced in the occurrence of urinary disorders after BT, and any intervention (TURP) should be performed at least 3-6 months after BT. This is especially crucial because of the development of radiation effect over time.
keywords:

prostate cancer, TURP, lower urinary tract symptoms, MR, brachytherapy, HDR-BT, urinary retention, orchiepididymitis, US examination, suprapubic cystostomy

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.